Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uro-Vaxom for UTI Prevention in SCI
NCT04049994Phase 4Completed
- Sponsor
- Swiss Paraplegic Research
- Start
- Jun 2020
- Primary completion
- Sep 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-89 in urinary tract infection (UTI), sponsored by Swiss Paraplegic Research. Started Jun 2020; status: completed.
02
Drugs
OM-89
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04049994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049994.